explore -WSS

explore

author：leisure time 2025-09-30 00:50:01 - browse：9

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： JPM 2024: Verve Therapeutics looks to mainstream genome editing

hotspot

WSS

Risky weight loss products often used by teens globally, per study

DeSantis can now import cheaper drugs. But will Biden get credit?

Crinetics acromegaly drug succeeds in late

The (many) problems with a new study criticizing cancer screening

Snackable artificial intelligence, expert AI, and the pharma industry

New England Journal of Medicine addresses racist history, slavery

hotspot

explore

Wikipedia

Sports medicine is finally prioritizing gender equality

Amazon on where the company's health care bets are headed next

Medical leaders decry Supreme Court decision on affirmative action

How to protect patients from sexual assault

Hepatitis C has a cure — but many Americans still lack access to it

ALS advocates say criticism of new drugs misses bigger picture

In age of alternative facts, a scholarly course on calling out crap

JPM 2024: Nvidia claims we're in biological revolution. Are we?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Biotech reporter’s notebook: A sunnier mood at JPM 2024

focus

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Risky weight loss products often used by teens globally, per study

HHS names first

Amazon on where the company's health care bets are headed next

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

A new House health package & hospitals’ new site

hotspot

Wikipedia

focus

entertainment